• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » BlackRock boosts medical device stakes

BlackRock boosts medical device stakes

January 30, 2013 By MassDevice staff

BlackRock Inc.

BlackRock Inc., 1 of the world’s largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception.

The New York-based firm increased its position in St. Jude Medical (NYSE:STJ), Sirona Dental Systems (NSDQ:SIRO) and Boston Scientific (NYSE:BSX) by double-digit percentages, according to regulatory filings. With other companies, the stakes seem to be newly acquired as of the end of 2012.

BlackRock, which has more than $3.51 trillion in assets under its umbrella, raised its share in St. Jude by more than 26%, owning about 19.6 million shares. Next up was Sirona, with a share boost of 19.5%, followed by Boston Scientific, with a 13.5% increase.

Notable new positions include Becton Dickinson & Co. (NYSE:BDX), Covidien (NYSE:COV) and Edwards Lifesciences (NYSE:EW). The lone exception to the buying spree was Varian Medical (NYSE:VAR); BlackRock pared its stake there by 1.1%, to roughly 5.5 million shares.

Here’s a look at the investments, with "n/a" denoting a new position:

Company Shares Stake % change
Becton Dickinson & Co. (NYSE:BDX) 10.3 million 5.2%  n/a
Boston Scientific (NYSE:BSX) 84.0 million 6.1% 13.5%
C.R. Bard (NYSE:BCR) 4.2 million 5.2% 5.2%
Covidien (NYSE:COV) 23.7 million 5.0%  n/a
DexCom Inc. (NSDQ:DXCM) 3.6 million 5.2% 7.6%
Edwards Lifesciences (NYSE:EW) 6.5 million 5.6%  n/a
Endologix (NSDQ:ELGX) 3.1 million 5.1% 8.7%
Grifols (NSDQ:GRFS) 11.0 million 5.2%  n/a
Hospira (NYSE:HSP) 10.5 million 6.4%  n/a
Mako Surgical (NSDQ:MAKO) 2.5 million 5.4%  n/a
Orthofix (NSDQ:OFIX) 993,000 5.1%  n/a
Philips (NYSE:PHG) 48.7 million 5.1%  n/a
Sirona Dental Systems (NSDQ:SIRO) 3.3 million 6.0% 19.5%
St. Jude Medical (NYSE:STJ) 19.6 million 6.4% 26.1%
Varian Medical (NYSE:VAR) 5.5 million 5.0% -1.1%

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: becton dickinson, BlackRock Inc., Boston Scientific, C.R. Bard, Covidien, Dexcom, Edwards Lifesciences, Endologix, Grifols, Hospira Inc., MAKO Surgical Corp., Orthofix, Philips, Sirona, stjudemedical, Varian Medical Systems

More recent news

  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy